A zebrafish model to study the role of chaperonins in Mycobacterial infection
A zebrafish model to study the role of chaperonins in Mycobacterial infection
批准号:
BB/S017526/1
负责人:
Peter Lund
金额:
$61.6万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The bacterium Mycobacterium tuberculosis causes the disease TB. This disease is the number one killer among all infectious diseases, with more than 95% of deaths occurring in lower and middle income countries. Although there is a vaccine, its effectiveness is poor. TB is usually treatable, though the treatment is lengthy and expensive, but some strains of TB are highly resistant to current drugs and survival rates in people infected with these strains are low. Ending the current TB epidemic by 2030 is one of the UN's Sustainable Development Goals, but this target will be missed if new treatments cannot be found. Similar diseases caused by the closely related organisms M. bovis and M. marinum are found in cattle (and other mammals) and fish respectively, and can cause losses in agriculture and fish farming. One of the reasons the bacterium is so effective is that it has several strategies to combat the immune system. These include having a cell wall which is hard for the immune system to spot, and being able to survive inside immune system cells that kill most other bacteria. It also causes the formation of structures called granulomas, made up from cells of the immune system, in which it can shelter for many years before emerging to cause disease or to infect other people. Understanding the process of infection and the formation of granulomas is key to better understanding the disease and devising new ways to treat or prevent it. M. tuberculosis, like nearly all bacteria, expresses proteins called "chaperonins". These are large complex proteins that help other proteins to achieve their final shape, which is required for them to function properly. Chaperonins are essential for all cells to grow and survive. The TB bacterium and its relatives are unusual however in that it makes two different kinds of chaperonin, neither of which appears to form the large complex that is typically seen with chaperonins from other bacteria. One of these is still essential, but the other is not. These proteins have taken on an additional role as well. They can cause cells in the body to secrete cytokines: these are molecules that can stimulate inflammation and help the immune system clear infections, but are also involved in granuloma formation. Scientists therefore looked to see whether these chaperonins might be important in causing granulomas to form, by deleting the gene for the non-essential chaperonin and using the resultant strains to infect mice and guinea pigs. It was found that although the bacteria still grew, they no longer caused granuloma formation, and that stimulation of the immune system normally seen with infection was much reduced. This was an important finding, but unfortunately M. tuberculosis is hard to study as it grows very slowly and the animal infection studies are slow and expensive. We therefore decided to see whether the same thing was true in the closely related (but faster growing) M. marinum. To do this we made a mutant strain that lacked the non-essential chaperonin and used it to infect embryos of zebrafish, where it normally causes granuloma formation. Indeed, the mutant organism no longer caused granuloma formation. If we put the gene back in, but now expressed at a higher level, we found that granulomas were now formed and infection happened as normal. Now that we have this assay, we plan to study the role of this protein in more detail. We already know which parts of the protein are important for its chaperone function, including its ability to form a large complex, and we have some data on which parts are important in stimulating the immune system. By mutating these regions or by expressing chaperonins from disease-causing Mycobacteria we can test our ideas about how the protein works in infection.This will help us determine whether the protein could be a potential target for new TB treatments in the future, including whether it would make a good target for a new vaccine.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Preparation of functional nanoparticles of mPEG - b - P ( DMA - co - HA ) copolymers via polymerization-induced thermal self-assembly
聚合诱导热自组装制备mPEG-b-P(DMA-co-HA)共聚物功能纳米颗粒
DOI:
10.1002/pol.20230420
发表时间:
2023
期刊:
Journal of Polymer Science
影响因子:
3.4
作者:
[Akar I]
通讯作者:
Akar I
DOI:
10.1039/d2mh01117d
发表时间:
2023-01-03
期刊:
Materials horizons
影响因子:
13.3
作者:
[]
通讯作者:
DOI:
10.3389/fmolb.2021.669996
发表时间:
2021
期刊:
Frontiers in molecular biosciences
影响因子:
5
作者:
[Kumar CMS, Chugh K, Dutta A, Mahamkali V, Bose T, Mande SS, Mande SC, Lund PA]
通讯作者:
Lund PA
Mycobacterial chaperonins as potential targets for new therapeutic approaches to tuberculosis
-
批准号:BB/V018302/1
-
项目类别:Research Grant
-
资助金额:$1.26万
-
财政年份:2021
-
负责人:Peter Lund
-
依托单位:
Towards predictive biology: using stress responses in a bacterial pathogen to link molecular state to phenotype.
-
批准号:BB/K019171/1
-
项目类别:Research Grant
-
资助金额:$40.87万
-
财政年份:2013
-
负责人:Peter Lund
-
依托单位:
Functional in vivo and in vitro analysis of the archaeal chaperonin complex
-
批准号:BB/F002483/1
-
项目类别:Research Grant
-
资助金额:$43.94万
-
财政年份:2007
-
负责人:Peter Lund
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于术中实时影像的SAM(Segment anything model)开发AI指导房间隔穿刺位置决策的增强现实模型
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:居维竹
-
依托单位:
运用3D打印和生物反应器构建仿生尿道模型探索Hippo-YAP信号通路调控尿道损伤修复的机制研究
-
批准号:82370684
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:傅强
-
依托单位:
基于影像代谢重塑可视化的延胡索酸水合酶缺陷型肾癌危险性分层模型的研究
-
批准号:82371912
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:吴广宇
-
依托单位:
高维隐含因子与定价误差的协同估计
-
批准号:72101226
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:丁一
-
依托单位:
新型二维/三维双体系癌症研究模型的建立
-
批准号:32070796
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:王霞
-
依托单位:
Development of a Linear Stochastic Model for Wind Field Reconstruction from Limited Measurement Data
-
批准号:--
-
项目类别:--
-
资助金额:40万元
-
批准年份:2020
-
负责人:Vikrant Gupta
-
依托单位:
半参数空间自回归面板模型的有效估计与应用研究
-
批准号:71961011
-
项目类别:地区科学基金项目
-
资助金额:16.0万元
-
批准年份:2019
-
负责人:丁飞鹏
-
依托单位:
高频数据波动率统计推断、预测与应用
-
批准号:71971118
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2019
-
负责人:孔新兵
-
依托单位:
人胆囊源CD63+细胞的干性特征与分化特性的研究
-
批准号:31970753
-
项目类别:面上项目
-
资助金额:52.0万元
-
批准年份:2019
-
负责人:胡以平
-
依托单位:
基于线性及非线性模型的高维金融时间序列建模:理论及应用
-
批准号:71771224
-
项目类别:面上项目
-
资助金额:49.0万元
-
批准年份:2017
-
负责人:王辉
-
依托单位: